CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes Chief Financial Officer gave up 356 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 277 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 782 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 370 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 497 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,648 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 699,475 shares at $2.69 ($1,882,077)
- 4 Open-market sale 10% owner sold 1,704 shares at $4.50 ($7,671)
- 4 Open-market sale 10% owner sold 454,261 shares at an average $4.59 ($2,085,238)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 614,710 shares at an average $6.13 ($3,765,522)
- 4 Derivatives Options or other derivatives
Page 13 of 21 · 414 filings